IN8bio, Inc. (INAB) stock

INABNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30

$0.82−0.00 (-0.04%)

Close on Nov 13, 2026Market cap $8.08MP/E –Yield –

IN8bio statistics

59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 11, 2027 (estimated, during market hours)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $8.08M; $272.32M
Enterprise Value: -$5.89M; $146.23M
PB Ratio: 0.57; 2.00
P/TBV Ratio: 0.57; 2.22

Share statisticsIndustry

Shares Outstanding: 10M; 58M
Shares Change (YoY): 373.8%; 10.8%
Shares Change (QoQ): 0.05%; 0.50%
Shares Held by Institutions: 38.4%; 56.4%

Short sellingIndustry

Short Interest: 15,733; –
Short Interest Change: -52.0%; -0.80%
Short % of Shares Outstanding: 0.16%; 6.30%
Days to Cover: 1.00; 5.15

Stock price statisticsIndustry

52-Week High: $2.73; –
52-Week Low: $0.80; –
20-Day Moving Average: $0.95; –
50-Day Moving Average: $1.10; –
200-Day Moving Average: $1.39; –
Average True Range (14): $0.09; –
Price Change (1 Week): -11.5%; -1.15%
Price Change (1 Month): -30.8%; -4.87%
Price Change (3 Months): -26.1%; -21.0%
Price Change (6 Months): -45.0%; -20.6%
Price Change (YTD): -65.0%; -23.6%
Price Change (1 Year): -51.8%; -22.4%
Price Change (3 Years): -97.2%; -29.5%
Price Change (5 Years): -99.7%; -77.9%
Average Volume (10 Days): 31,999; –
Average Volume (20 Days): 34,455; –
Average Volume (90 Days): 51,771; –
Relative Volume: 0.15; 0.70
Relative Strength Index (14): 34.9; 43.4
Volatility (1 Year): 86.8%; 80.1%
Beta (5 Years): 1.37; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -141.8%; -49.9%
Return on Assets (ROA): -109.4%; -40.6%
Return on Invested Capital (ROIC): -1135.1%; -32.9%
Return on Capital Employed (ROCE): -120.8%; -37.9%

Financial positionIndustry

Current Ratio: 5.78; 3.30
Quick Ratio: 5.32; 2.39

EfficiencyIndustry

Profits Per Employee: -$1.14M; -$689.41K
Employee Count: 17; 74
WACC: 12.0%; 10.2%

Income statement (TTM)Industry

Operating Income: -$19.41M; -$21.37M
Net Income: -$19.41M; -$22.35M
EBITDA: -$19.41M; -$17.21M
EPS (Diluted): -$1.45; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $13.97M; $68.68M
Net Cash (Debt): $13.97M; $17.76M
Net Cash Per Share: $1.42; $0.80
Equity (Book Value): $14.17M; $53.89M
Book Value Per Share: $1.44; $1.50
Tangible Book Value: $14.17M; $27.13M
Working Capital: $12.57M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$14.76M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -240.0%; -21.8%
Buyback Yield: -1.26%; -0.76%
Shareholder Yield: -1.26%; 0.00%

Scores and fair valueIndustry

Altman Z-Score: -13.20; 0.23
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	INAB	S&P 500	Difference	INAB per year	S&P 500 per year
1 month	-30.5%	-3.0%	−27.5 pts
3 months	-30.5%	-2.8%	−27.7 pts
Year to date	-65.0%	+11.5%	−76.4 pts
1 year	-50.0%	+13.5%	−63.5 pts
3 years	-97.4%	+77.7%	−175.1 pts	-70.4%	+21.1%
5 years	-99.7%	+72.6%	−172.3 pts	-68.2%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M INAB shares were sold short on Oct 30, 2026, down 52.0% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 41.1% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	15,733	-52.0%	36,207	1.0
Oct 15, 2026	32,797	-29.4%	46,395	1.0
Sep 30, 2026	46,440	-26.4%	53,488	1.0
Sep 15, 2026	63,110	-30.5%	28,616	2.2
Aug 31, 2026	90,842	-35.1%	55,295	1.6
Aug 14, 2026	139,903	+461.6%	98,439	1.4
Jul 31, 2026	24,913	+19.8%	55,386	1.0
Jul 15, 2026	20,789	-40.8%	53,283	1.0
Jun 30, 2026	35,117	-23.5%	37,497	1.0
Jun 15, 2026	45,907	-57.3%	55,764	1.0
May 29, 2026	107,416	-33.6%	82,583	1.3
May 15, 2026	161,813	-34.1%	52,250	3.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?